In order to maximize the predictive power of differentially expressed immune-associated genes, we ensured that the four genes (CCL14, KLKB1, VIPR1, and CD4) chosen for development as an IMOPP for HCC had P values of less than 0.1 for overall or disease-free survival. This evidence concerns the gene VIPR1 and hepatocellular carcinoma.